This bone marrow stromal cell–G6PD axis regulates the redox state of prostate cancer cells, with a loss of G6PD elevating ROS, decreasing antioxidants, and enhancing the chemosensitivity of prostate cancer cells. This evidence concerns the gene G6PD and prostate carcinoma.